Astellas Pharma Canada Named to the 2020 List of Best Workplaces™ for Healthcare This is the second year in a row Astellas has been named to the List of Best Workplaces™ for Healthcare and comes in addition to five other awards this year from Great Place to Work®. MARKHAM, ON, September 15, 2020 - Astellas Pharma Canada has been recognized again by the Great Place to Work® Institute to the 2020...

Astellas Pharma Canada Named Again to the 2020 Great Place to Work® List of Best Workplaces™ for Giving Back This is the second year in a row Astellas has received the distinction that recognizes employers who make a difference in their community. MARKHAM, ON, August 25, 2020 - Astellas Pharma Canada, Inc. has been recognized again by the Great Place to Work® Institute on the 2020 List of Best...

XTANDI® is the first and only androgen receptor-axis-targeted therapy (ARAT) approved by Health Canada in three clinical disease states of prostate cancer across four indications[ii]

At Astellas we empower our employees and encourage a culture that is achievement oriented and allows everyone to work to their full potential. It is exactly these high-trust and high-performance workplace cultures that are selected by Great Place to Work®, a global authority that recognizes the world's Best Workplaces™. We are very excited to have been named a Best Workplaces™ by the Great Place...

Astellas ranked 27 on the Great Place to Work® Institute's Best Workplaces™ in Canada list, in addition to recognition on the 2020 lists of Best Workplaces™ in Canada for Inclusion and Women MARKHAM, ON, April 16, 2020 – Astellas Pharma Canada, Inc. has been named on the List of Best Workplaces™ by Great Place to Work® for the fifth consecutive year. In addition to being certified as a Great Place...